Tech Company Financing Transactions
Senzo Funding Round
On 12/14/2022, Senzo announced $1.9 million in financing from BioAdvance Ventures, Wellness Coaches and private investors.
Transaction Overview
Company Name
Announced On
12/14/2022
Transaction Type
Venture Equity
Amount
$1,900,000
Round
Undisclosed
Investors
BioAdvance Ventures (Lead Investor) (Gregory Harriman)
Wellness Coaches (Lead Investor)
Proceeds Purpose
The company intends to use the funds to complete validation, execute clinical trials, secure FDA EUA authorization, and scale manufacturing for the ALF COVID-19 test, as well as to advance R&D for new Flu A/B, RSV, Tuberculosis, HIV, Hepatitis-C, and Strep tests.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10 West Rd. 1011
Newtown, PA 18940
USA
Newtown, PA 18940
USA
Phone
Undisclosed
Website
Email Address
Overview
Senzo is an in vitro diagnostics company developing innovative, accurate, and accessible testing products. Senzo is creating game-changing products and systems which bring testing to the patient, eliminating the need for the current slow, expensive central-lab testing paradigms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jared Slosberg
Chief Executive Officer
Jeremy Stackawitz
Chief Technical Officer
Youba Diakite
President
Aron Rachamim
VP - Bus. Development
Jacob Raby
VP - Regulatory Affairs
Nataliya Noreika
Browse more venture capital transactions:
Prev: 12/14/2022: Calvin Risk venture capital transaction
Next: 12/14/2022: Frontrunner venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs